Immunocytochemistry with patient-derived GBM NS (GBM30) exhibited colocalization of FOXM1 with MELK within individual cells (72.5% ± 2.4% colocalization in Fig. 3B). The gene discussed is FOXM1; the disease is glioblastoma.